Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Additions to Abcodia

Premium

Cancer biomarker developer Abcodia has appointed Mike Fisher to be director of business development and Steve Pereira as a specialist advisor.

Fisher, who will lead the firm's commercial activities, formerly was business development director at Bio Nano Consulting and a senior advisor to the UK government and the North American UK Trade and Investment Network for the Life Science Industry.

Pereira, who will advise the company on developing biomarkers for early diagnosis and screening of pancreatic cancer, is a consultant gastroenterologist at several hospitals in London and is chairman of the British Society of Gastroenterology's Pancreatic Section.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.